Back to Search
ALLEN MANGEL, MD
MD
Research Study Specialist
NPI: 1689915969Individual
Specialties, Licenses & Credentials
Research Study SpecialistPrimary
Specialist — Research Study
Code: 1744R1102X
39193(NC)
Research & Publications (20)
Design of treatment trials in irritable bowel syndrome: opioid agonists and atypical benzodiazepine antagonists.
PMID 18826559·Neurogastroenterol Motil·2008
6-review
Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.
PMID 18466359·Aliment Pharmacol Ther·2008
2-rct
Personal view: adequate relief as a primary endpoint in irritable bowel syndrome.
PMID 16573790·Aliment Pharmacol Ther·2006
6-review
Evaluation of crofelemer in the treatment of diarrhea-predominant irritable bowel syndrome patients.
PMID 19092244·Digestion·2008
2-rct
Gastrointestinal side effects in chronic opioid users: results from a population-based survey.
PMID 18363893·Aliment Pharmacol Ther·2008
8-other
Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
PMID 17973974·Aliment Pharmacol Ther·2008
3-trial
Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints.
PMID 17428741·Clin Gastroenterol Hepatol·2007
6-review
Adequate relief in IBS treatment trials: corrections to errors stated by Whitehead et al.
PMID 17227528·Am J Gastroenterol·2006
8-other
Determinants of healthcare-seeking behaviour among subjects with irritable bowel syndrome.
PMID 16696818·Aliment Pharmacol Ther·2006
8-other
Stability of irritable bowel syndrome using a Rome II-based classification.
PMID 16393298·Aliment Pharmacol Ther·2006
8-other
Global endpoints in functional gastrointestinal disease.
PMID 16305732·Aliment Pharmacol Ther·2005
8-other
Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey.
PMID 16268967·Aliment Pharmacol Ther·2005
8-other
Calcium-dependent, swelling-activated K+ conductance in human neuroblastoma cells.
PMID 12927783·Biochem Biophys Res Commun·2003
8-other
A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome.
PMID 11485506·Arch Intern Med·2001
3-trial
A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia.
PMID 11284782·Aliment Pharmacol Ther·2001
3-trial
Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome.
PMID 11232690·Am J Gastroenterol·2001
3-trial
Mice lacking the dopamine transporter display altered regulation of distal colonic motility.
PMID 10915639·Am J Physiol Gastrointest Liver Physiol·2000
7-preclinical
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial.
PMID 10744088·Lancet·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 208 UKIAH LN
CHAPEL HILL, NC 27514 - Phone
- (919) 931-9862
Quick Facts
- NPI
- 1689915969
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile